BIOLOGICAL RESPONSE MODIFIERS ADVISORY COMMITTEE
July 13, 2001
Slides
Responses to FDA Gene Therapy Letter: Adenovirus Vector Titer Measurements and RCA Levels, Steven R Bauer, PhD, FDA ppt html
Overview of Adenoviral Vectors and Titer Determination, C Estuardo Aguilar-Cordova, MD, Harvard University ppt html
RCA Assays and Clinical Data For a rAD-p53 in Cancer Patients, Beth Hutchins, PhD, Canji, Inc. ppt html
Absence of RCA Isolated from Patients Treated with INGN 201 (Ad5CMV-p53), Richard Sublett, PhD, Introgen Therapeutics ppt html
Adenovirus Infections in Immunocompromised Hosts, Phyllis Flomenberg, MD, Thomas Jefferson University ppt html